TürkçeTracheal tumors are benign or malignant masses that develop within the windpipe, narrowing the airway and impairing respiratory function. These tumors typically present with progressive shortness of breath, persistent cough, and stridor. If not detected at an early stage, they may lead to severe airway obstruction.
Symptoms of tracheal tumors include progressive dyspnea, hemoptysis, hoarseness, and recurrent lower respiratory tract infections. Clinical findings are often mistaken for asthma or chronic bronchitis. Therefore, prolonged respiratory complaints that do not respond to treatment require further evaluation.
The diagnosis of tracheal tumors is established through bronchoscopic examination and radiological imaging techniques. Computed tomography provides detailed information about the tumor’s location and extent. Definitive diagnosis is determined by histopathological evaluation, and the tumor type directly influences the treatment plan.
Treatment of tracheal tumors includes surgical resection, endoscopic interventions, and, in appropriate cases, radiotherapy or chemotherapy. The choice of treatment is planned according to the tumor’s histological type, stage, and the patient’s overall condition. Appropriate treatment performed at an early stage significantly improves survival rates.
Where Is the Trachea Located and How Does It Function in the Respiratory System?
The trachea, commonly known as the windpipe, is the main airway responsible for safely carrying the fresh air we inhale to the lungs while allowing the stale air inside the lungs to be expelled. In an average adult, this structure measures approximately ten to twelve centimeters in length and extends from the larynx to the central portion of the chest cavity. Upon reaching the center of the thoracic cavity, it divides into the right and left main bronchi, providing entry into both lungs. The anatomical structure of the trachea consists of stacked C-shaped cartilaginous rings that remain open at the back. Numbering between sixteen and twenty, these cartilage rings prevent the airway from collapsing against the negative and positive pressure changes occurring in the chest during breathing. As a result, the airway remains continuously open, allowing uninterrupted airflow.
The open posterior portion of these cartilage rings is completed by a flexible membrane and muscle tissue. This flexibility is not accidental; the esophagus lies directly behind the trachea, and during swallowing, large food boluses can pass comfortably into the stomach without compressing the airway because of this flexible posterior wall. The inner lining of the trachea is covered with microscopic hair-like structures called cilia and specialized cells that secrete a slippery substance known as mucus. This lining traps dust, smoke, bacteria, and other microscopic particles inhaled with the air, preventing them from reaching the deepest parts of the lungs. These trapped particles are continuously swept upward by the cilia and eventually expelled as sputum. Therefore, the trachea is not simply a passive tube but also a highly active and vital defense barrier protecting the lungs from harmful environmental factors.
How Has Airway and Tracheal Surgery Evolved Throughout Medical History?
Humanity’s efforts to treat airway diseases date back centuries, long before the advent of modern medicine. In Anatolia, the roots of surgical practice extend as far back as the fourteenth century, when medical terminology gradually began to be expressed in Turkish. This scientific process, initiated by distinguished physicians such as Hekim Bereket and İshak bin Murad, reached an academic foundation with Şerafettin Sabuncuoğlu’s remarkable work “Cerrahiyyetü’l Haniyye,” written in 1465. Sabuncuoğlu not only illustrated the surgical instruments of his era but also described in remarkable detail the procedure of creating an opening into the trachea through the neck to restore breathing. In the centuries that followed, advances in anatomical knowledge combined with surgical experience led to a much deeper understanding of the human body. Beginning in the fifteenth century, consent documents known as “huccet,” signed between surgeons and patients, became some of the earliest historical examples of what is now recognized as informed consent before medical procedures.
The institutional development of modern thoracic surgery accelerated during the nineteenth century with the establishment of medical schools. Intensive research on the surgical treatment of pulmonary infections and tuberculosis in the early twentieth century greatly expanded anatomical knowledge of the thoracic cavity. Particularly during the 1930s, Rudolph Nissen’s pioneering work at Istanbul University significantly advanced the field of tracheal surgery. By the 1950s, the comprehensive thoracic surgery texts published by Fahri Arel laid the foundation for the tracheal resection techniques used today, in which a diseased segment of the trachea is removed and the healthy ends are reconnected. Today, tracheal diseases are treated safely using advanced imaging technologies, sophisticated anesthesia techniques, and multidisciplinary approaches built upon centuries of accumulated medical knowledge.
How Common Are Tracheal Tumors and Who Is Most Commonly Affected?
Masses formed by uncontrolled and abnormal cell growth within the body are generally referred to as tumors. While cancers affecting the lungs are relatively common, tracheal tumors belong to a very rare group of diseases. They account for only a tiny percentage of all malignant tumors affecting the respiratory tract. Statistical data indicate that the annual incidence of primary tumors originating directly from the trachea is less than one case per one hundred thousand individuals. Large autopsy series from previous decades have even reported tracheal tumors in only one out of approximately fifteen thousand cases.
However, their rarity does not diminish their clinical significance. Approximately sixty to eighty percent of diagnosed tracheal masses are malignant. The remaining tumors are benign. Nevertheless, even a benign tumor within the trachea should never be considered harmless. Regardless of its cellular nature, any mass occupying and narrowing the airway poses a direct threat to life by interfering with breathing and therefore requires prompt treatment.
Into Which Major Histological Subtypes Are Malignant Tracheal Tumors Classified?
Malignant tumors arising within the trachea are classified into different categories according to their microscopic cellular characteristics. These cellular differences directly influence the tumor’s growth rate, tendency to spread, treatment strategy, and the typical age group affected.
The main types of malignant tracheal tumors include:
- Squamous cell carcinoma
- Adenoid cystic carcinoma
- Carcinoid tumors
- Mucoepidermoid carcinomas
The most common type encountered in adults is squamous cell carcinoma. The development of this tumor is strongly associated with tobacco use. It typically occurs in individuals in their fifties and sixties who have a long history of heavy smoking. Owing to its biological characteristics, it tends to grow rapidly and has an early tendency to spread to the surrounding lymph nodes. Because of its aggressive growth, symptoms of airway obstruction usually develop more quickly and become clinically apparent earlier.
The second most common subtype, adenoid cystic carcinoma, behaves quite differently. It has no established direct association with smoking and generally occurs in younger patients, often in their forties. Adenoid cystic carcinoma grows slowly, and symptoms may take years to develop. However, its most distinctive and challenging feature is its tendency to spread along nerve sheaths. The tumor may extend microscopically beyond its visible margins by tracking along nerves outside the trachea. Because of this slow yet insidious pattern of spread, many patients already have distant pulmonary involvement by the time the diagnosis is established.
What Symptoms Commonly Develop as Tracheal Tumors Grow?
One of the greatest clinical challenges posed by tracheal tumors is that they often progress silently during their early stages. The human trachea is sufficiently wide to allow normal airflow even when a growing mass is present. Consequently, symptoms usually do not appear until the tumor narrows at least fifty to seventy percent of the airway lumen. Until this critical level of obstruction is reached, patients frequently remain completely asymptomatic.
Once this threshold is exceeded, the most common symptoms include:
- Progressive exertional shortness of breath
- Shortness of breath at rest
- High-pitched wheezing
- Coughing up blood
- Persistent dry cough
- Unexplained hoarseness
- Difficulty swallowing solid foods
The most common symptom is progressively worsening shortness of breath. Initially, breathing difficulty occurs only during activities such as climbing stairs, carrying heavy objects, or brisk walking. As the tumor enlarges, however, patients eventually experience breathlessness even while resting. One of the most alarming signs of critical airway narrowing is stridor—a high-pitched, whistle-like sound heard particularly during inhalation. This indicates that air is being forced through a severely narrowed passage and represents an emergency warning of life-threatening airway obstruction. In smoking-related squamous cell carcinoma, rupture of blood vessels or ulceration of the tumor surface frequently leads to hemoptysis. Furthermore, involvement of the recurrent laryngeal nerve by the tumor may result in persistent hoarseness, while posterior tumor extension compressing the esophagus can cause swallowing difficulties.
Why Is the Diagnosis of Tracheal Tumors Often Delayed and How Can They Be Mistaken for Asthma?
One of the greatest challenges in diagnosing airway tumors is that their symptoms closely resemble those of far more common respiratory diseases. When patients present with shortness of breath, cough, and wheezing, physicians naturally consider asthma, chronic bronchitis, or chronic obstructive pulmonary disease as the most likely diagnoses. Consequently, inhalers, bronchodilators, and corticosteroids are often prescribed initially.
This creates a misleading situation. Asthma medications and corticosteroids can temporarily reduce the inflammation and swelling surrounding the tumor, producing a short-lived improvement in symptoms. Patients may believe the treatment is effective, while physicians may incorrectly assume that the asthma diagnosis has been confirmed. Unfortunately, this false sense of improvement delays recognition of the true underlying problem. As the tumor continues to enlarge, asthma medications eventually become ineffective. Particularly in older adults with no previous history of asthma or allergies, the sudden onset of wheezing that progressively worsens despite appropriate treatment should always raise suspicion for a mechanical airway obstruction or tracheal tumor. Delayed recognition of this possibility may postpone diagnosis for months, allowing the tumor to progress beyond the limits of surgical treatment.
Which Imaging Techniques Are Used to Diagnose Suspected Tracheal Tumors?
When appropriate clinical suspicion exists, diagnosis begins with detailed radiological imaging. Although conventional chest radiographs serve as the initial imaging method for many respiratory disorders, they are generally inadequate for detecting tracheal tumors. This is because the trachea lies in the center of the chest behind the shadows cast by the spine, heart, and major blood vessels, making tumors difficult to visualize.
The primary imaging techniques include:
- Computed tomography of the neck and chest
- Three-dimensional airway reconstruction
- Positron emission tomography
- Magnetic resonance imaging for advanced disease
Computed tomography produces thin cross-sectional images that provide excellent visualization of both the inside and outside of the trachea. CT imaging reveals how many centimeters the tumor extends, the percentage of airway narrowing, and—most importantly—the relationship between the tumor and critical structures such as the aorta. Positron emission tomography is used to determine the overall extent, or stage, of the disease. Because cancer cells consume glucose much more rapidly than normal cells, patients receive an injection of a radioactive glucose analog after a period of fasting. Approximately one hour later, PET imaging identifies tumors and metastatic lymph nodes as brightly illuminated areas where the radioactive glucose has accumulated. This comprehensive assessment allows physicians to determine both the local characteristics of the tumor and the overall extent of disease, enabling optimal treatment planning.
Why Is Bronchoscopy Essential for Diagnosing Tracheal Tumors and Managing Airway Emergencies?
Although imaging techniques provide excellent anatomical information, bronchoscopy is indispensable for evaluating the cellular characteristics of the tumor and directly examining the tracheal lining. Bronchoscopy involves inserting specialized instruments equipped with powerful light sources and high-definition cameras into the airways for direct visualization. Two principal bronchoscopic techniques are employed.
Flexible bronchoscopy is generally performed first. Conducted under local anesthesia with the patient awake or lightly sedated, the flexible bronchoscope is inserted through the nose or mouth. The physician carefully examines the tumor’s mucosal borders, documents its surface characteristics, and obtains tissue samples using miniature instruments passed through the bronchoscope. These specimens undergo pathological examination to establish the exact histological diagnosis.
Rigid bronchoscopy, in contrast, is performed under general anesthesia in the operating room. This straight metallic instrument serves not only diagnostic purposes but also life-saving therapeutic interventions. If a patient presents with near-complete airway obstruction and impending suffocation, rigid bronchoscopy allows mechanical removal of portions of the obstructing tumor. Rapid restoration of airway patency improves oxygenation, stabilizes the patient, and creates much safer conditions for definitive cancer surgery.
Which Definitive Surgical Techniques Are Used for Early-Stage Tracheal Tumors?
The most effective and definitive treatment for tracheal tumors is complete surgical removal of the affected tracheal segment. This procedure, known as tracheal resection with end-to-end anastomosis, involves circumferential removal of the diseased portion of the airway followed by reconnection of the healthy ends. For malignant tumors, the primary surgical objective is complete tumor removal with negative margins, leaving no microscopic cancer cells behind.
Different surgical approaches are selected depending on the tumor’s location:
- Horizontal incision at the lower neck
- Partial or complete division of the sternum
- Right thoracotomy through the ribs
- Special approach through the pericardium
Tumors located near the larynx can often be reached through a small neck incision, whereas tumors closer to the bronchial bifurcation require opening the sternum or chest wall. Typically, four to six centimeters of the human trachea can be safely removed, although this varies depending on patient age, neck anatomy, and tissue flexibility. Reconnecting the remaining tracheal ends represents the most technically demanding part of the operation. Excessive tension on the suture line may compromise blood supply, impair healing, or lead to suture disruption. To minimize this risk, the patient’s chin is positioned toward the chest during surgery, allowing the trachea to relax and facilitating tension-free reconstruction. In more complex cases, additional release maneuvers involving the hyoid bone or pulmonary ligaments may be performed to further reduce tension.
Which Endoscopic Treatments Are Used for Inoperable Tracheal Tumors?
When diagnosis is delayed, tumors may extend beyond the trachea into the aorta, pericardium, or esophagus, making complete surgical removal impossible. Similarly, advanced age or severe coexisting illnesses such as heart failure may render patients unsuitable for major surgery. In these situations, although complete tumor eradication is not possible, interventional bronchoscopic procedures play a crucial role in relieving airway obstruction and preserving quality of life.
Laser therapy is among the most frequently used techniques. High-energy laser beams delivered through the bronchoscope vaporize tumor tissue obstructing the airway, rapidly restoring airflow. Since the tumor itself remains, regrowth may occur over time. Consequently, laser therapy is often used either to relieve acute respiratory distress or as a bridge before radiotherapy.
The main types of airway stents include:
- Removable silicone stents
- Self-expanding covered metallic stents
- Uncovered metallic stents
- Dynamic stents that mimic natural anatomy
Airway stents are supportive tube-like or mesh structures inserted into the trachea to maintain airway patency by continuously exerting outward pressure. They physically prevent tumor tissue from obstructing the airway. Following stent placement, patients typically experience immediate relief from the sensation of suffocation, can clear respiratory secretions more effectively, and are at lower risk of developing life-threatening lung infections such as pneumonia.
How Do Recovery, Oncological Treatment, and Follow-Up Progress After Tracheal Tumor Surgery?
Following tracheal surgery, patients typically remain hospitalized for one to two weeks. Surgery represents only the first stage of treatment, while postoperative intensive care and ward management are equally critical to successful outcomes. During the early postoperative period, protecting the tracheal anastomosis is essential. To prevent the patient from accidentally extending the neck and placing tension on the suture line, a heavy retention suture is placed between the chin and chest at the end of surgery, keeping the neck flexed forward for approximately one week. Respiratory physiotherapy is also initiated to facilitate coughing and airway clearance.
Following discharge, the resected tumor undergoes detailed pathological evaluation. Depending on surgical margins and lymph node involvement, additional oncological treatment may be required. Particularly for tumors with a tendency to spread along nerves, postoperative radiotherapy is routinely administered to reduce the risk of recurrence, even after technically successful surgery. Chemotherapy may also be incorporated when indicated.
Long-term follow-up includes:
- Comprehensive physical examinations
- Standard chest radiographs
- High-resolution computed tomography
- Pulmonary function testing
- Follow-up bronchoscopy when indicated
Patients are initially reviewed monthly, with follow-up intervals gradually extending to every three months, six months, and eventually annually. These evaluations carefully monitor for recurrent airway narrowing and detect any new disease elsewhere in the body.
Frequently Asked Questions
Tracheal tumors typically present with shortness of breath, cough, wheezing, and changes in the voice. Because these symptoms can easily be mistaken for asthma or bronchitis, diagnosis is sometimes delayed.
Although tracheal tumors can also cause shortness of breath and wheezing, they often do not respond adequately to standard asthma or COPD treatments. Progressive airway obstruction may indicate the presence of a tumor.
Smoking may increase the risk of certain respiratory tract tumors. In addition, prolonged exposure to chemicals and chronic airway irritation may also contribute to the development of tracheal tumors.
Computed tomography provides detailed information about the tumor’s location, size, and the degree of airway narrowing. It also helps evaluate its relationship with surrounding tissues, contributing to treatment planning.
Bronchoscopy enables direct visualization of the trachea and allows biopsy samples to be obtained from suspicious tissue. This helps determine the tumor type and establish the most appropriate treatment strategy.
A biopsy determines whether the tumor is benign or malignant. Identifying its cellular characteristics is essential for planning surgery, radiotherapy, or other treatment options.
Surgery may be the preferred treatment for patients whose tumors are localized and can be completely removed. The primary goal is to eliminate the tumor while restoring the airway’s normal function as much as possible.
Radiotherapy may be used in patients who are not suitable candidates for surgery or who require additional treatment. Chemotherapy and endoscopic interventions may also be considered as part of the treatment plan in selected cases.
Regular follow-up helps detect possible recurrence or airway complications at an early stage. Imaging studies and clinical evaluations play a crucial role in monitoring long-term outcomes.
Tumors that narrow the airway can make breathing difficult and limit physical activity. Early diagnosis and appropriate treatment can help preserve respiratory function and improve quality of life.
Prof. Dr. Alper Fındıkcıoğlu graduated from Istanbul University Faculty of Medicine and completed his thoracic surgery residency at Dr. Siyami Ersek Hospital. He began his academic career at Başkent University in 2005; he received the title of associate professor in 2014 and professor in 2022. He has extensive experience in lung cancer, chest wall diseases, and minimally invasive surgery. Since 2024, he has been continuing his professional work at Acıbadem Hospital.
